Diabetes is a condition where the body has problems controlling blood sugar levels. There are two main types of Diabetes Mellitus.
In Diabetes Type I, the body mounts and in immune response (autoimmune) to its own insulin-producing beta cells in the pancreas and damages said cells. In Diabetes Type II, there is either an insufficient production of insulin or the insulin that is produced is not responded to well by the peripheral cells (insulin-resistance). Diabetes Type II is manageable with the proper diet and exercise in most cases whereas Diabetes Type I requires that patients test their blood sugar levels regularly and administer insulin as necessary through an injection or a pump.
Mesenchymal stem cells derived from the bone marrow as well as from endometrial tissue are the cells that we use at the Stem Cell Healing Institute. We find this combination successful for Autoimmune Disease and inflammation. They are multipotent cells that can generate multiple cell lineages. We specifically inject directly into the Pancreatic Circulation as well as the Inguinal Lymph Node. This targets and modulates the antibodies that attack the beta cells of the Pancreas. The cells are injected into the patient where they will allocate to the pancreas and either support the repair of beta cells in the patient or ideally differentiate into beta cells themselves which would then regulate the levels of insulin in the patient’s body.
Depending and the type of Diabetes, the treatment, amount of cells and number of times the procedure is repeated and the results will vary.
Stem Cells Transl Med. 2013 May; 2(5): 328–336. Published online 2013 Apr 9. doi: 10.5966/sctm.2012-0116. Preeti Chhabra and Kenneth L. Brayman
2. Regenerative Therapy of Type 1 Diabetes Mellitus: From Pancreatic Islet Transplantation to Mesenchymal Stem Cells
Stem Cells Int. 2016; 2016: 3764681.Published online 2016 Mar 7. doi: 10.1155/2016/3764681. Nadine E. Rekittke, Meidjie Ang, Divya Rawat, Rahul Khatri, and Thomas Linn
3. Analysis of type II diabetes mellitus adipose-derived stem cells for tissue engineering applications
J Tissue Eng. 2015 Jan-Dec; 6: 2041731415579215. Published online doi: 10.1177/2041731415579215
Danielle Marie Minteer, Matthew T Young, Yen-Chih Lin, Patrick J Over, J Peter Rubin, Jorg C Gerlach,and Kacey G Marra